NCT03895619

Brief Summary

Despite effective strategies to reduce periconception HIV transmission, there are few services to support people living with or affected by HIV to use these methods. In particular, there is a lack of safer conception services focused on engaging men living with HIV. Given known gender inequities in childbearing decision-making and HIV risk, it is critical that safer conception services deliver programming that engages men living with HIV and their HIV sero-different partners. The Healthy Families program, based at the ISS Clinic at Mbarara Regional Referral Hospital, offers client-centered safer conception care to help HIV-affected individuals and couples meet reproductive goals. This care supports clients to leverage personal motivations and partner and social supports to overcome structural barriers and use Antiretroviral Therapy (ART), adopt other HIV-prevention strategies, and remain in care. This pilot study (the 'Getting to Zero' study) will assess uptake and experiences of safer conception care among 50 men living with HIV and their HIV sero-different partners. Investigators will also assess men's retention in HIV care and HIV transmission risk to partners and infants. This is a one-year mixed-methods prospective pilot research study, which will use electronic chart review data, longitudinal survey data (from the male index and female partner participant), and qualitative data from in-depth semi-structured interviews to meet study objectives. By demonstrating safer conception uptake and impact on HIV transmission risks to partners and infants, investigators aim to inform HIV and reproductive health policy in Uganda and globally.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at below P25 for not_applicable hiv-infections

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2018

Completed
28 days until next milestone

Study Start

First participant enrolled

November 26, 2018

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 29, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2019

Completed
Last Updated

April 17, 2020

Status Verified

April 1, 2020

Enrollment Period

10 months

First QC Date

October 29, 2018

Last Update Submit

April 15, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of HIV infected men and their female partners attending Safer Conception Counselling Sessions and choosing a safer conception strategy that meets their needs

    We will document the number of participants who return to their clinic with their female pregnancy partner to attend Safer Conception Counselling. We will also document the type of strategy chosen.

    1.5 year

Secondary Outcomes (5)

  • Types of factors contributing to uptake of safer conception strategies among men living with HIV

    1.5 year

  • Number of men living with HIV retained in care who are part of the safer conception intervention.

    1.5 year

  • HIV transmission incidence among HIV-affected individuals and couples where the male partner is living with HIV and engaged in the safer conception intervention.

    1.5 year

  • Periconception HIV transmission incidence among HIV-affected individuals and couples.

    1.5 year

  • HIV incidence among female partners of men living with HIV engaged in the safer conception intervention.

    1.5 year

Study Arms (1)

Men living with HIV

EXPERIMENTAL

Uptake of safer conception strategies among men living with HIV and/or their female partners

Other: Safer conception strategies

Interventions

Individuals and couples adopt safer conception strategies including HIV-serostatus disclosure to partner, ART uptake and adherence and HIV-RNA suppression, STI testing and treatment, timing condomless sex to peak fertility, partner ARV use (ART if living with HIV, PrEP if HIV negative), and contraception until ready to conceive.

Men living with HIV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For enrollment in the Getting to Zero study, eligibility criteria for the index participant include the following:
  • Identify as male
  • HIV-positive
  • Report personal or partner desire to have a child in the next year
  • Identified pregnancy partner is reported to be HIV-negative or he doesn't know her HIV serostatus.
  • Aged 18 years or older.
  • Be naïve to the Healthy Families program.
  • Live within 60km of the ISS clinic and not planning to relocate to an area incompatible with an ability to attend the clinic over a 1 year follow-up period.
  • Able and willing to participate in the informed consent process.
  • Identify as a partner of an enrolled male Getting to Zero participant
  • Aged 18 years or older
  • Able and willing to participate in the informed consent process.
  • These participants will be referred to as the "partner". If the female partner is identified as HIV-positive after the male index participant enrolls in the Getting to Zero study, both partners remain eligible to participate.

You may not qualify if:

  • Identify as female
  • HIV-negative
  • Does not report personal or partner desire to have a child in the next year
  • Identified pregnancy partner is reported to be HIV-positive
  • Under age 18 years.
  • Be a patient of the Healthy Families program.
  • Live greater than 60km of the ISS clinic and planning to relocate to an area incompatible with attending the clinic over a 1 year follow-up period.
  • Unable and unwilling to participate in the informed consent process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Immune Suppression Syndrome (ISS) Clinic at the Mbarara Regional Referral Hospital (MRRH)

Mbarara, Uganda

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Proof of Concept Research
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 29, 2018

First Posted

March 29, 2019

Study Start

November 26, 2018

Primary Completion

September 26, 2019

Study Completion

October 31, 2019

Last Updated

April 17, 2020

Record last verified: 2020-04

Locations